Gregory Davis in

Gregory Davis

Login to view DISC.
Founder and Principal Consultant at GenElement LLC
📍 San Francisco Bay Area, United States

Gregory is a biotech leader with over 25 years of experience, currently serving as the Head of Research and Technology at Sangamo Therapeutics. He has been instrumental in the development and commercialization of three major genome editing technologies: ZFNs, CRISPR, and RNA-guided retrotransposons. He holds a Ph.D. from the University of Oklahoma.

Outside of his direct research, Gregory shows a deep appreciation for the people who have shaped his career. He has publicly expressed immense gratitude for his Ph.D. advisor, highlighting the importance of mentorship in science and staying connected to foundational scientific principles.

He played a key role in launching the worlds first commercial genome editing tools for human somatic cell research.

Read the full overview →
Experience
35 Years
Current Role
Founder and Principal Consultant
Job Level
Leadership
Location
San Francisco Bay Area, United States
Personality Overview

How Gregory shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Gregory cares about

Genome Editing Platforms
He has played a key role in the tech development, intellectual property, and commercialization of three major genome editing technologies: ZFNs, CRISPR, and Targetrons.
Zinc Finger Engineering
Leads teams at Sangamo focused on discovering and optimizing novel zinc finger proteins (ZFPs) and translating them into genomic medicines.
+5 more topics Login to view topics
Career

Work history

3-2026
Founder and Principal Consultant
GenElement LLC
10-2024 - 6-2026
Head of Research and Technology
Sangamo Therapeutics, Inc.
11-2023 - 10-2024
Head of Technology
Sangamo Therapeutics, Inc.
5-2020 - 11-2023
Vice President, Genome Engineering
Sangamo Therapeutics, Inc.
11-2015 - 5-2020
Head of Genome Engineering R&D
MilliporeSigma
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1988 - 1993
B.S.
The University of Texas at Austin
1993 - 1998
Ph.D.
University of Oklahoma
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Gregory. Free, 10 seconds.